Measles-containing-vaccine second-dose (MCV2) immunization coverage in Burkina Faso
Burkina Faso: Measles-containing-vaccine second-dose (MCV2) immunization coverage was 65.0% in 2025. ◆ Volatile
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Burkina Faso, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for measles-containing-vaccine second-dose (mcv2) immunization coverage in Burkina Faso is 65.0%, measured in 2025.
The figure is up 30.0% over ten years.
Over the whole period, measles-containing-vaccine second-dose (mcv2) immunization coverage in Burkina Faso peaked at 71.0% in 2018 and was at its lowest, 0.0%, in 2000.
Burkina Faso ranks 153rd of 194 countries on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Burkina Faso, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 0.0% | — |
| 2007 | 0.0% | — |
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 0.0% | — |
| 2013 | 0.0% | — |
| 2014 | 17.0% | — |
| 2015 | 50.0% | +194.1% |
| 2016 | 59.0% | +18.0% |
| 2017 | 65.0% | +10.2% |
| 2018 | 71.0% | +9.2% |
| 2019 | 71.0% | +0.0% |
| 2020 | 71.0% | +0.0% |
| 2021 | 71.0% | +0.0% |
| 2022 | 66.0% | -7.0% |
| 2023 | 65.0% | -1.5% |
| 2024 | 65.0% | +0.0% |
| 2025 | 65.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 10 |
| 2010s | 33.3% | 0.0% | 71.0% | 10 |
| 2020s | 67.2% | 65.0% | 71.0% | 6 |
Countries ranked near Burkina Faso
More health data for Burkina Faso
- Un projection of annual infant deaths, annual growth rate -1.67 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.8925 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,142 deaths per 1,000 people (2090)
- Number of infants who die before age 1 13,085 deaths (2100)
- Total tetanus - number of reported cases, gaps filled 199 (2025)
- Total tetanus - number of reported cases, per capita 0 units per person (2025)
- Diphtheria - number of reported cases, gaps filled 2 (2025)
- Diphtheria - number of reported cases, per capita 0 units per person (2025)
- Measles - number of reported cases, gaps filled 4,099 (2025)
- Measles - number of reported cases, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is measles-containing-vaccine second-dose (mcv2) immunization coverage in Burkina Faso?
- Measles-containing-vaccine second-dose (mcv2) immunization coverage in Burkina Faso was 65.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Burkina Faso?
- The highest recorded value was 71.0% in 2018.
- What is the lowest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Burkina Faso?
- The lowest recorded value was 0.0% in 2000.
- How does Burkina Faso rank for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Burkina Faso ranks 153rd out of 194 countries with data for 2025.
- Is measles-containing-vaccine second-dose (mcv2) immunization coverage rising or falling in Burkina Faso?
- Over the last ten years it is up 30.0%. The long-run trend across the full record is volatile.
- Where does this Burkina Faso data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).